In our previous works, it was revealed that overexpression of GOLPH3 promoted the progression of prostate cancer from hormone sensitive stage to hormone stage, and GOLPH3's potential as a novel biomarker and potential target for antagonizing castration resistant prostate cancer (23). The gene discussed is GOLPH3; the disease is prostate cancer.